IP Library Granted Patent US 7,857,746
Granted Patent B2
US 7,857,746 · App. 10/977,734 · Granted Dec 28, 2010

System and method to reduce discomfort using nerve stimulation

Assignee: Nueronetics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,857,746
App. No.
10/977,734
Granted
Dec 28, 2010
Kind
B2
Abstract

A novel method and system for performing transcutaneous magnetic stimulation is disclosed herein. In the method, a first magnetic field is generated using a first magnetic stimulation device for transcutaneously stimulating a treatment area, and a second magnetic field for transcutaneously stimulating the treatment area is generated by a second magnetic stimulation device. In addition, a novel method and system for reducing discomfort caused by transcutaneous magnetic stimulation is disclosed herein. In the method, a first magnetic field is created at a first and second location using a first magnetic stimulation device. The first magnetic field causes magnetic stimulation at the first and second locations. A second magnetic field is created at the second location using a second magnetic stimulation device, thereby reducing stimulation at the second location.

Claims (36)

1. A method for performing transcutaneous magnetic stimulation, comprising:

creating a first magnetic field at a first and second location using a first magnetic stimulation device, wherein the first magnetic field causes magnetic stimulation at the first and second locations; and

adjusting a placement of a second magnetic stimulation device with respect to the first magnetic stimulation device to create a second magnetic field at the second location that destructively interferes with the first magnetic field at the second location, wherein the magnetic stimulation at the first location is sufficient for the transcutaneous magnetic stimulation.

2. The method of claim 1 , wherein the magnetic stimulation at the second location is reduced by reducing a magnetic field flux density at the second location.

3. The method of claim 1 , wherein the first location is a treatment area.

4. The method of claim 1 , wherein the second location is a treatment area.

5. The method of claim 1 , wherein the first location is a brain.

6. The method of claim 5 , wherein the second location is a cranial nerve.

7. The method of claim 5 , wherein the second location is a trigeminal nerve.

8. The method of claim 1 , wherein the second location is a location that is sensitive to pain.

9. The method of claim 1 , wherein reducing the stimulation at the second location comprises over-stimulating the second location with the second magnetic field.

10. The method of claim 9 , wherein the over-stimulation reduces the second location's sensitivity to pain.

11. The method of claim 10 , wherein the over-stimulation reduces the second location's ability to respond to the magnetic stimulation.

12. The method of claim 11 , wherein the over-stimulation prevents the second location from repolarizing.

13. The method of claim 1 , further comprising detecting the first magnetic field, and wherein the second magnetic field is created based on the detected first magnetic field.

14. The method of claim 1 , wherein the magnetic stimulation is canceled with a magnetic field.

15. The method of claim 1 , wherein the method is used for the treatment of depression or schizophrenia.

16. A system for performing transcutaneous magnetic stimulation, comprising:

a first magnetic stimulation device for creating a first magnetic field for transcutaneously stimulating a first and second location; and

a second magnetic stimulation device adapted for adjusting the placement of the second magnetic stimulation device with respect to the first magnetic stimulation device to create a second magnetic field for destructively interfering with the first magnetic field at the second location, wherein the magnetic stimulation at the first location is sufficient for the transcutaneous magnetic stimulation.

17. The system of claim 16 , further comprising a stimulator circuit in communication with the first and second magnetic stimulation devices.

18. The system of claim 17 , wherein the stimulator circuit provides a first signal to the first magnetic stimulation device and a second signal to a second magnetic stimulation device.

19. The system of claim 18 , wherein the first and second signals are different.

20. The system of claim 16 , wherein the first and second magnetic stimulation devices are oriented as a function of their magnetic fields.

21. The system of claim 16 , wherein the first and second magnetic stimulation devices have a different characteristic.

22. The system of claim 21 , wherein the different characteristic is a different shape.

23. The system of claim 21 , wherein the different characteristic is a different size.

24. The system of claim 23 , wherein the first magnetic stimulation device is larger than the second magnetic stimulation device.

25. The system of claim 16 , wherein the first and second magnetic stimulation devices have a ferromagnetic core.

26. The system of claim 25 , wherein the first magnetic stimulation device has flat wire windings disposed around its ferromagnetic core.

27. The system of claim 25 , wherein the second magnetic stimulation device has flat wire windings disposed around its ferromagnetic core.

28. The system of claim 16 , wherein the first magnetic stimulation device is adapted to be placed on a head.

29. The system of claim 16 , wherein the first magnetic stimulation device is placed proximate a peripheral nerve.

30. The system of claim 16 , wherein power is provided to the first and second magnetic stimulation devices at a substantially similar time for a substantially similar duration.

31. The system of claim 30 , wherein the power is pulsed to the first and second magnetic stimulation devices at substantially the same time.

32. The system of claim 30 , wherein the power is pulsed to the first and second magnetic stimulation devices at a substantially different time.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2024
From: SLR INVESTMENT CORP.
To: NEURONETICS, INC.
Reel/Frame 068479/0343 →
SECURITY INTEREST Recorded Jul 26, 2024
From: NEURONETICS, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 068174/0177 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 4, 2020
From: NEURONETICS, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 052091/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2005
From: RIEHL, MARK EDWARD
To: NEURONETICS, INC.
Reel/Frame 016100/0263 →
Continuity (1)
Related Publication 20060094924A1 · May 4, 2006